RESUMEN
Injectable hydrogels have been developed as biomedical materials in various fields but the biofouling on their surface limits applications in vivo. In this work, a zwitterionic structure was introduced into an injectable hydrogel based on thermosensitive nanogels to overcome the foreign body reaction. The hydrodynamic diameter of the resultant poly(N-isopropylacrylamide-co-sulfobetaine methacrylate) (PNS) nanogels was ca. 105 nm. The aqueous dispersion with a high content of PNS nanogels showed a flowable sol state at room temperature, and turned into a hydrogel in situ at â¼36 °C due to the thermosensitivity of the PNS nanogels. In particular, the resulting hydrogel exhibited lower biofouling both in vitro and in vivo in comparison with similar hydrogels without a zwitterionic structure. Polydopamine nanoparticles (PDA NPs) as a photothermal agent and an anti-tumour drug could be easily co-loaded in the injectable hydrogel. Under near-infrared (NIR) irradiation for 10 min, the temperature of the PNS system containing PDA NPs could reach ca. 38 °C. The drug release from the in situ-forming hydrogel could be accelerated by NIR laser irradiation, and showed a sustainable release behavior and adjustability. The results of intratumoral injection of the as-prepared injectable hydrogel containing PDA NPs and an anti-tumour drug showed significant anticancer effects combining photothermal therapy and local chemotherapy. This constructed injectable zwitterionic thermosensitive hydrogel is easy to use with the advantage of low-fouling and may become a promising platform for various biomedical applications.
Asunto(s)
Acrilamidas/administración & dosificación , Antineoplásicos/administración & dosificación , Betaína/análogos & derivados , Hidrogeles/administración & dosificación , Fototerapia/métodos , Acrilamidas/química , Acrilamidas/metabolismo , Adsorción , Animales , Antineoplásicos/química , Antineoplásicos/metabolismo , Betaína/administración & dosificación , Betaína/química , Betaína/metabolismo , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Terapia Combinada/métodos , Relación Dosis-Respuesta a Droga , Células Hep G2 , Humanos , Hidrogeles/química , Hidrogeles/metabolismo , Ratones , Carga Tumoral/efectos de los fármacos , Carga Tumoral/fisiologíaRESUMEN
Mild hyperthermia has been used in combination with polymer therapeutics to further increase delivery to solid tumors and enhance efficacy. An attractive method for generating heat is through non-invasive high intensity focused ultrasound (HIFU). HIFU is often used for ablative therapies and must be adapted to produce uniform mild hyperthermia in a solid tumor. In this work a magnetic resonance imaging guided HIFU (MRgHIFU) controlled feedback system was developed to produce a spatially uniform 43°C heating pattern in a subcutaneous mouse tumor. MRgHIFU was employed to create hyperthermic conditions that enhance macromolecular delivery. Using a mouse model with two subcutaneous tumors, it was demonstrated that MRgHIFU enhanced delivery of both Evans blue dye (EBD) and Gadolinium-chelated N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers. The EBD accumulation in the heated tumors increased by nearly 2-fold compared to unheated tumors. The Gadolinium-chelated HPMA copolymers also showed significant enhancement in accumulation over control as evaluated through MRI T1-mapping measurements. Results show the potential of HIFU-mediated hyperthermia for enhanced delivery of polymer therapeutics.
Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Ultrasonido Enfocado de Alta Intensidad de Ablación/métodos , Hipertermia Inducida/métodos , Sustancias Macromoleculares/administración & dosificación , Acrilamidas/administración & dosificación , Acrilamidas/metabolismo , Animales , Azul de Evans/administración & dosificación , Azul de Evans/metabolismo , Gadolinio/administración & dosificación , Gadolinio/metabolismo , Sustancias Macromoleculares/metabolismo , Imagen por Resonancia Magnética , Ratones Endogámicos , Neoplasias Experimentales/diagnóstico por imagen , Neoplasias Experimentales/metabolismo , Compuestos Organometálicos/administración & dosificación , Compuestos Organometálicos/metabolismo , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
The present study aimed to investigate the metabolism of Entadae Semen by human fecal bacteria to clarify the relationship between its pharmacological activities and intestinal metabolism. Three major components (phaseoloidin, entadamide A-ß-D-glucopyranoside and entadamide A) were isolated and identified from Entadae Semen and then incubated with human fecal microflora in vitro to investigate the metabolic processes. The metabolites were analyzed with high-performance liquid chromatography (HPLC). The anti-complement activities of the three components and their metabolites produced by human fecal microflora were evaluated in vitro using a hemolysis assay. Phaseoloidin and entadamide A-ß-D-glucopyranoside were metabolized into their respective aglycones during the incubation process, which enhanced their anti-complement effects. These results indicated that the presence of intestinal bacteria likely plays an important role and that the pharmacological effects of Entadae Semen may be dependent on intestinal bacterial metabolism.
Asunto(s)
Bacterias/metabolismo , Proteínas del Sistema Complemento/metabolismo , Fabaceae/química , Mucosa Intestinal/metabolismo , Extractos Vegetales/metabolismo , Semillas/química , Acrilamidas/metabolismo , Acrilamidas/farmacología , Animales , Cromatografía Líquida de Alta Presión , Heces/microbiología , Cobayas , Humanos , Intestinos/microbiología , Extractos Vegetales/farmacología , ConejosRESUMEN
Biodegradation studies of Gum ghatti (Gg) and acrylamide-co-acrylic acid based flocculants [Gg-cl-poly(AAm-co-AA)] have been reported using the soil composting method. Gg-cl-poly(AAm-co-AA) was found to degrade 89.76% within 60 days. The progress of biodegradation at each stage was monitored through FT-IR and SEM. Polymer was synthesized under pressure using potassium persulphate-ascorbic acid as a redox initiator and N,N'-methylene-bis-acrylamide as a crosslinker. Synthesized polymer was found to show pH, temperature and ionic strength of the cations dependent swelling behavior. Gg-cl-poly(AAm-co-AA) was utilized for the selective absorption of saline from different petroleum fraction-saline emulsions. The flocculation efficiency of the polymer was studied as a function of polymer dose, temperature and pH of the solution. Gg-cl-poly(AAm-co-AA) showed maximum flocculation efficiency with 20 mol L(-1) polymer dose in acidic medium at 50 °C.
Asunto(s)
Acrilamidas/química , Acrilamidas/metabolismo , Gomas de Plantas/metabolismo , Absorción , Floculación , Concentración de Iones de Hidrógeno , Concentración Osmolar , Petróleo/análisis , TemperaturaRESUMEN
Besides its quintessential role in reproduction, 17ß-estradiol (E2) is a potent anorexigenic hormone. E2 and the selective Gq-coupled membrane estrogen receptor (Gq-mER) ligand STX rapidly increase membrane excitability in proopiomelanocortin (POMC) neurons by desensitizing the coupling of GABAB receptors to G protein-coupled inwardly rectifying K(+) channels (GIRKs), which upon activation elicit a hyperpolarizing outward current. However, it is unknown whether E2 and STX can modulate GABAB signaling in neuropeptide Y (NPY)/agouti-related peptide (AgRP) neurons. We used single-cell RT-PCR and whole cell patch clamping with selective pharmacological reagents to show that NPY/AgRP cells of mice express the GABAB-R1 and -R2 receptors and are hyperpolarized by the GABAB agonist baclofen in an E2-dependent manner. In males, E2 rapidly attenuated the coupling of GABAB receptors to GIRKs, which was blocked by the general PI3K inhibitors wortmannin and LY-294002 or the selective p110ß subunit inhibitor TGX-221. The ERα-selective agonist propyl pyrazole triol mimicked the effects of E2. STX, in contrast, enhanced the GABAB response in males, which was abrogated by the estrogen receptor (ER) antagonist ICI 182,780. In gonadectomized mice of both sexes, E2 enhanced or attenuated the GABAB response in different NPY/AgRP cells. Coperfusing wortmannin with E2 or simply applying STX always enhanced the GABAB response. Thus, in NPY/AgRP neurons, activation of the Gq-mER by E2 or STX enhances the GABAergic postsynaptic response, whereas activation of ERα by E2 attenuates it. These findings demonstrate a clear functional dichotomy of rapid E2 membrane-initiated signaling via ERα vs. Gq-mER in a CNS neuron vital for regulating energy homeostasis.
Asunto(s)
Acrilamidas/farmacología , Estradiol/farmacología , Receptor alfa de Estrógeno/metabolismo , Hipotálamo/metabolismo , Neuronas/metabolismo , Neuropéptido Y/metabolismo , Receptores de GABA-B/metabolismo , Acrilamidas/metabolismo , Animales , Baclofeno/farmacología , Estradiol/metabolismo , Femenino , Agonistas de Receptores GABA-B/farmacología , Cobayas , Masculino , Ratones , Ratones Transgénicos , Técnicas de Placa-Clamp , Transducción de SeñalRESUMEN
The synthesis and biological evaluation of 3,4,5-trimethoxyphenyl acrylamides 1a-f as novel antinarcotic agents are described. The molecules were prepared by the Wittig reaction, followed by a coupling reaction between 3,4,5-trimethoxycinnamic acid (9) and aliphatic amines, which resulted in good yields. When tested for biological activity, compounds 1d-f exhibited strong inhibitory effects on the morphine withdrawal syndrome in mice due to their high binding affinities with serotonergic 5-HT1A receptors.
Asunto(s)
Acrilamidas/síntesis química , Acrilamidas/farmacología , Antagonistas de Narcóticos/síntesis química , Antagonistas de Narcóticos/farmacología , Acrilamidas/química , Acrilamidas/metabolismo , Animales , Células Cultivadas , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Espectroscopía de Resonancia Magnética , Ratones , Ratones Endogámicos C57BL , Antagonistas de Narcóticos/química , Antagonistas de Narcóticos/metabolismo , Ensayo de Unión Radioligante , Receptor de Serotonina 5-HT1A/efectos de los fármacos , Espectrometría de Masa por Ionización de ElectrosprayRESUMEN
A series of potent and selective EP(3) receptor antagonists are described. Utilizing a pharmacophore model developed for the EP(3) receptor, a series of 3,4-disubstituted indoles were found to be efficient ligands for this target. These compounds showed high selectivity over IP, FP and other EP receptors. An optimized molecule 7c featured a sound profile and potency in the functional rat and human platelet aggregation assays.
Asunto(s)
Acrilamidas/síntesis química , Acrilamidas/metabolismo , Indoles/síntesis química , Indoles/metabolismo , Receptores de Prostaglandina E/antagonistas & inhibidores , Acrilamidas/farmacología , Animales , Células CHO , Cricetinae , Cricetulus , Perros , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos/métodos , Estabilidad de Medicamentos , Haplorrinos , Humanos , Indoles/farmacología , Ratones , Ratas , Receptores de Prostaglandina E/metabolismo , Subtipo EP3 de Receptores de Prostaglandina ERESUMEN
Intercellular adhesion molecule (ICAM)-1988 is a small molecule lymphocyte function-associated antigen-1 (LFA-1) antagonist being considered for its anti-inflammatory properties. Following intravenous administration of ICAM1988, clearances in mice, rats, dogs, and monkeys were 17.8, 3.31, 15.4, and 6.85 ml min(-1) kg(-1), respectively. In mass balance studies using [(14)C]-ICAM1988 in rats dosed intravenously, unchanged ICAM1988 contributed to 25.1% of the dose. In rats, the systemic bioavailability of ICAM1988 was improved to 0.28 when the drug was administered orally as its isobutyl ester, ICAM2660. In rats, this was consistent with the complete in vitro conversion of ICAM2660 to ICAM1988 in plasma, and liver and intestinal S9. In dogs and monkeys, ICAM2660 did not improve the bioavailability of ICAM1988. This is consistent with limited in vitro conversion of ICAM2660 to ICAM1988 in plasma and liver S9. In human in vitro studies, ICAM2660 conversion to ICAM1988 in liver was similar to rats while no conversion in plasma and intestinal S9 fractions were observed. Based on the in vitro metabolism similarities of human and rat, it would be anticipated that in human oral administration of ICAM2660 would improve the systemic exposure of ICAM1988.
Asunto(s)
Acrilamidas/metabolismo , Acrilamidas/farmacocinética , Moléculas de Adhesión Celular/metabolismo , Moléculas de Adhesión Celular/farmacocinética , Antígeno-1 Asociado a Función de Linfocito/metabolismo , Profármacos/metabolismo , Profármacos/farmacocinética , beta-Alanina/análogos & derivados , Absorción/efectos de los fármacos , Acrilamidas/química , Acrilamidas/farmacología , Animales , Moléculas de Adhesión Celular/química , Moléculas de Adhesión Celular/farmacología , Perros , Evaluación Preclínica de Medicamentos , Estabilidad de Medicamentos , Haplorrinos , Humanos , Inyecciones Intravenosas , Hígado/efectos de los fármacos , Hígado/metabolismo , Ratones , Profármacos/química , Profármacos/farmacología , Ratas , Distribución Tisular/efectos de los fármacos , beta-Alanina/química , beta-Alanina/metabolismo , beta-Alanina/farmacocinética , beta-Alanina/farmacologíaRESUMEN
The family of Kv7 (KCNQ) potassium channels consists of five members. Kv7.2 and 3 are the primary molecular correlates of the M-current, but also Kv7.4 and Kv7.5 display M-current characteristics. M-channel modulators include blockers (e.g., linopirdine) for cognition enhancement and openers (e.g., retigabine) for treatment of epilepsy and neuropathic pain. We investigated the effect of a Bristol-Myers Squibb compound (S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide [(S)-1] on cloned human Kv7.1-5 potassium channels expressed in Xenopus laevis oocytes. Using two-electrode voltage-clamp recordings we found that (S)-1 blocks Kv7.1 and Kv7.1/KCNE1 currents. In contrast, (S)-1 produced a hyperpolarizing shift of the activation curve for Kv7.2, Kv7.2/Kv7.3, Kv7.4 and Kv7.5. Further, the compound enhanced the maximal current amplitude at all potentials for Kv7.4 and Kv7.5 whereas the combined activation/block of Kv7.2 and Kv7.2/3 was strongly voltage-dependent. The tryptophan residue 242 in S5, known to be crucial for the effect of retigabine, was also shown to be critical for the enhancing effect of (S)-1 and BMS204352. Furthermore, no additive effect on Kv7.4 current amplitude was observed when both retigabine and (S)-1 or BMS204352 were applied simultaneously. In conclusion, (S)-1 differentially affects the Kv7 channel subtypes and is dependent on a single tryptophan for the current enhancing effect in Kv7.4.
Asunto(s)
Acrilamidas/farmacología , Canales de Potasio KCNQ/efectos de los fármacos , Morfolinas/farmacología , Neuronas/metabolismo , Acrilamidas/metabolismo , Algoritmos , Animales , Sitios de Unión/efectos de los fármacos , ADN Complementario/biosíntesis , ADN Complementario/genética , Electrofisiología , Humanos , Canales de Potasio KCNQ/genética , Canal de Potasio KCNQ1/efectos de los fármacos , Canal de Potasio KCNQ2/efectos de los fármacos , Cinética , Morfolinas/metabolismo , Neuronas/efectos de los fármacos , Oocitos/efectos de los fármacos , Oocitos/metabolismo , Técnicas de Placa-Clamp , Mutación Puntual/efectos de los fármacos , Triptófano/efectos de los fármacos , Triptófano/metabolismo , Xenopus laevisRESUMEN
N-(2-Hydroxypropyl)methacrylamide (HPMA) copolymer carrier containing the anticancer drug doxorubicin bound either by a proteolytically degradable bond (non-targeted PK1 or targeted with alpha-CD71 mAb) or by a hydrolytically degradable bond were synthesised and tested in vivo for various biological properties. Mouse 38C13 B-cell lympoma was used as a well established and defined cell line for this study. 38C13 cells are sensitive to free doxorubicin and IC50 was very low, about 0.014 microM. PK1 showed a strongly decreased cytostatic effect, IC50 being 12.6 microM. alpha-CD71 targeted conjugate, which can be considered as an antibody-targeted form of PK1, had IC50 0.358 microM. HPMA copolymer with doxorubicin bound via a hydrolytically sensitive bond (HYD conjugate) showed a high cytostatic effect with IC50 about 0.052 microM. We demonstrated that HYD conjugate inhibited DNA synthesis and induced p21(Waf1/Cip1) protein expression (p21(Waf1/Cip1) is cyclin-dependent kinase inhibitor which blocks cell cycle progression) as quickly as free doxorubicin, whereas PK1 acted much more slowly. Similarly, apoptosis induction measured by Annexin V binding and Caspase 3 activity was detected later after incubation of cells with PK1 or alpha-CD71 targeted conjugate. Apoptosis was manifested by elevation of bax and bad mRNA levels, which was much more rapid and intense in the case of free doxorubicin and HYD conjugate. Expression of antiapoptotic genes as well as cyclin-dependent kinases was surprisingly not affected.
Asunto(s)
Acrilamidas/síntesis química , Acrilamidas/farmacología , Doxorrubicina/síntesis química , Doxorrubicina/farmacología , Ligandos , Acrilamidas/metabolismo , Animales , Apoptosis/efectos de los fármacos , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Caspasa 3 , Caspasas/efectos adversos , Caspasas/efectos de los fármacos , Caspasas/metabolismo , Ciclo Celular/genética , Proteínas de Ciclo Celular/genética , Proteínas de Ciclo Celular/metabolismo , Línea Celular Tumoral , Membrana Celular/efectos de los fármacos , Membrana Celular/patología , Proliferación Celular/efectos de los fármacos , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , ADN/antagonistas & inhibidores , ADN/genética , ADN/metabolismo , Doxorrubicina/metabolismo , Evaluación Preclínica de Medicamentos/métodos , Expresión Génica/efectos de los fármacos , Expresión Génica/genética , Genes myc/efectos de los fármacos , Genes myc/genética , Hidrazonas/síntesis química , Hidrazonas/metabolismo , Hidrazonas/farmacología , Hidrólisis , Concentración 50 Inhibidora , Ratones , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , ARN Mensajero/genética , Receptores de Transferrina/efectos de los fármacos , Receptores de Transferrina/genética , Timidina/metabolismo , Tritio , Proteína X Asociada a bcl-2 , Proteína Letal Asociada a bclRESUMEN
Glucose, fructose, sucrose, free asparagine, and free glutamine were analyzed in 74 potato samples from 17 potato cultivars grown in 2002 at various locations in Switzerland and different farming systems. The potential of these potatoes for acrylamide formation was measured with a standardized heat treatment. These potentials correlated well with the product of the concentrations of reducing sugars and asparagine. Glucose and fructose were found to determine acrylamide formation. The cultivars showed large differences in their potential of acrylamide formation which was primarily related to their sugar contents. Agricultural practice neither influenced sugars and free asparagine nor the potential of acrylamide formation. It is concluded that acrylamide contents in potato products can be substantially reduced primarily by selecting cultivars with low concentrations of reducing sugars.